|
|
Xanitos is a privately-held corporation owned 30.1% by our CEO, Graeme A. Crothall and his family; 23.9% by other Xanitos management; 27.7% by three equity funds; and 18.3% by various individuals . Xanitos is well-capitalized, with further capital available from existing shareholders if needed for funding growth. Its strategy is to continue its current rapid organic growth, using its cash flow to first fund growth, and later to pay dividends or buy back shares. Xanitos' revenues have increased five times over the last three years and exceed $130M per year today. Sampling of clients:
| Medical Center |
Location |
Beds |
Cleanable Square Feet |
| Froedtert Memorial Lutheran Hospital |
Milwaukee |
450
|
1,830,000 |
| Children’s Hospital of Wisconsin |
Milwaukee |
236 |
975,000 |
| Kaiser Permanente Fontana Medical Center |
California |
440 |
1,800,000
|
| Kaiser Permanente San Diego Medical Center |
California |
392 |
1,702,000 |
| Kaiser Permanente Oakland Medical Center |
California |
349 |
855,000 |
| St. Alexius Medical Center |
Chicago |
330
|
300,000 |
| Resurrection Medical Center |
Chicago |
360 |
616,812 |
| Metro Health Hospital |
Michigan |
208 |
421,000 |
| South Shore Medical Center |
Boston |
284 |
506,000 |
| Wyoming Health Care Center |
Pennsylvania |
418 |
585,000
|
| Memorial Hospital |
Chattanooga |
475 |
937,000 |
| Athens Regional Medical Center |
Georgia |
315 |
838,000 |
|
|